Artera vs SOPHiA GENETICS (2026): Pricing, Features & Which to Choose

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

Lower starting price
Not comparable
Not comparable: Artera does not list a price
Free plan
Tie
Neither has one
Higher rating
Artera
4.4 against 3.9
Same job?
Yes
Both are Healthcare AI tools

Side by side

Compared on	Artera	SOPHiA GENETICS
Our rating	4.4Better	3.9
Starts at	Not listed	Not listed
Free plan	No	No
Category	Healthcare AI	Healthcare AI
Plans	See pricing	See pricing
Key features	Multimodal AI trained on digitized biopsy images paired with clinical data FDA De Novo authorization for the ArteraAI Prostate Test FDA clearance for ArteraAI Breast digital pathology risk stratification Results delivered in as little as two days after sample submission Inclusion in National Comprehensive Cancer Network (NCCN) treatment guidelines	SOPHiA DDM - AI genomic and radiomic analysis platform 98-99% accuracy across 2.6M+ analyzed genomic profiles Oncology coverage - solid tumors, blood cancers, hereditary cancers, liquid biopsy Rare and inherited disorder analysis HIPAA/GDPR-compliant cloud infrastructure
Pros	Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups Published clinical evidence showing improved outcome prediction versus existing risk models Adopted by a meaningful share of US prostate cancer clinicians already	Accuracy claims are backed by scale (2.6M+ profiles), not a small validation sample Deployed across a genuinely large, verifiable institutional network (1,000+ sites, 75+ countries) Covers both oncology and rare/inherited disorder use cases
Cons	Not a self-serve software product; access runs through labs, clinicians, and insurance billing Pricing is not public and varies by payer and region Limited to prostate and breast cancer currently, not a general oncology platform	No published pricing - an institutional sales process Built for healthcare institutions, not individual practitioners or patients directly Requires integration into existing clinical genomics/pathology workflows
Company	Artera, founded 2021	SOPHiA GENETICS

Prices come from each vendor's pricing page, last checked 20260824. Check the vendor before you buy.

FAQ

Questions people ask

Is Artera better than SOPHiA GENETICS?

In our reviews Artera scores 4.4 and SOPHiA GENETICS scores 3.9. The better pick depends on the job. Artera: FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. SOPHiA GENETICS: AI genomic analytics at 98-99% accuracy, deployed across 1,000+ healthcare institutions in 75+ countries - 2.6 million-plus genomic profiles analyzed to date.

Which is cheaper, Artera or SOPHiA GENETICS?

Artera: see pricing. SOPHiA GENETICS: see pricing.

Do Artera and SOPHiA GENETICS have free plans?

Neither lists a free plan.

More comparisons

Artera compared with

All Artera alternatives

SOPHiA GENETICS compared with

All SOPHiA GENETICS alternatives